BDX•prnewswire•
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs
Summary
Introduces BD Neopak™ Glass Prefillable Syringe production in Columbus, Nebraska FRANKLIN LAKES, N.J., Jan. 13, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million investment to expand its...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 13, 2026 by prnewswire